Literature DB >> 24391301

The challenges of global case reporting during pandemic A(H1N1) 2009.

Stephanie Williams1, Julia Fitzner1, Angela Merianos1, Anthony Mounts1.   

Abstract

During the 2009 A(H1N1) influenza pandemic, the World Health Organization (WHO) asked all Member States to provide case-based data on at least the first 100 laboratory-confirmed influenza cases to generate an early understanding of the pandemic and provide appropriate guidance to affected countries. In reviewing the pandemic surveillance strategy, we evaluated the utility of case-based data collection and the challenges in interpreting these data at the global level. To do this, we assessed compliance with the surveillance recommendation and data completeness of submitted case records and described the epidemiological characteristics of up to the first 110 reported cases from each country, aggregated into regions. From April 2009 to August 2011, WHO received over 18 000 case records from 84 countries. Data reached WHO at different time intervals, in different formats and without information on collection methods. Just over half of the 18 000 records gave the date of symptom onset, which made it difficult to assess whether the cases were among the earliest to be confirmed. Descriptive epidemiological analyses were limited to summarizing age, sex and hospitalization ratios. Centralized analysis of case-based data had little value in describing key features of the pandemic. Results were difficult to interpret and would have been misleading if viewed in isolation. A better approach would be to identify critical questions, standardize data elements and methods of investigation, and create efficient channels for communication between countries and the international public health community. Regular exchange of routine surveillance data will help to consolidate these essential channels of communication.

Entities:  

Mesh:

Year:  2013        PMID: 24391301      PMCID: PMC3865545          DOI: 10.2471/BLT.12.116723

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  26 in total

Review 1.  The global impact of influenza on morbidity and mortality.

Authors:  L Simonsen
Journal:  Vaccine       Date:  1999-07-30       Impact factor: 3.641

2.  Epidemiology of new influenza A(H1N1) in the United Kingdom, April-May 2009.

Authors: 
Journal:  Euro Surveill       Date:  2009-05-14

3.  New influenza A(H1N1) virus infections: global surveillance summary, May 2009.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-05-15

4.  New influenza A(H1N1) virus infections in France, April - May 2009.

Authors: 
Journal:  Euro Surveill       Date:  2009-05-28

5.  Minimum dataset needed for confirmed human H5N1 cases.

Authors:  Sheila M Bird; Jeremy Farrar
Journal:  Lancet       Date:  2008-08-14       Impact factor: 79.321

6.  Epidemiology of influenza A(H1N1)v virus infection in Japan, May-June 2009.

Authors:  T Shimada; Y Gu; H Kamiya; N Komiya; F Odaira; T Sunagawa; H Takahashi; T Toyokawa; Y Tsuchihashi; Y Yasui; Y Tada; N Okabe
Journal:  Euro Surveill       Date:  2009-06-18

7.  Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April - 3 October 2009.

Authors:  G Cullen; J Martin; J O'Donnell; M Boland; M Canny; E Keane; A McNamara; A O'Hora; M Fitzgerald; S Jackson; D Igoe; D O'Flanagan
Journal:  Euro Surveill       Date:  2009-11-05

8.  Epidemiological summary of pandemic influenza A (H1N1) 2009 virus - Ontario, Canada, June 2009.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-11-20

9.  Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-08       Impact factor: 17.586

10.  Update: swine influenza A (H1N1) infections--California and Texas, April 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-01       Impact factor: 17.586

View more
  3 in total

1.  Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors.

Authors:  Keyang Yuan; Mengwu Xiao; Ying Tan; Jiao Ye; Yongle Xie; Xiaoxiao Sun; Aixi Hu; Wenwen Lian; Ailin Liu
Journal:  Mol Divers       Date:  2017-05-23       Impact factor: 2.943

2.  Influenza activity in the Eastern Mediterranean Region (EMR) in 2020-2021 amidst the COVID-19 pandemic.

Authors:  Hala Abou El Naja; Stefano Tempia; Amal Barakat; Amgad Elkholy; Amir Aman; Wasiq Khan; Abdinasir Abubakar
Journal:  BMJ Glob Health       Date:  2022-06

3.  Accuracy of epidemiological inferences based on publicly available information: retrospective comparative analysis of line lists of human cases infected with influenza A(H7N9) in China.

Authors:  Eric H Y Lau; Jiandong Zheng; Tim K Tsang; Qiaohong Liao; Bryan Lewis; John S Brownstein; Sharon Sanders; Jessica Y Wong; Sumiko R Mekaru; Caitlin Rivers; Peng Wu; Hui Jiang; Yu Li; Jianxing Yu; Qian Zhang; Zhaorui Chang; Fengfeng Liu; Zhibin Peng; Gabriel M Leung; Luzhao Feng; Benjamin J Cowling; Hongjie Yu
Journal:  BMC Med       Date:  2014-05-28       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.